Oligomannose-Coated Liposome as a Novel Adjuvant for the Induction of Cellular Immune Responses to Control Disease Status
Figure 4
Elimination of established tumor by administration of OML-based vaccine. Mice () were challenged by s.c. injection of E.G7-OVA tumor cells in the right dorsal area on day 0. On day 9, OML/OVA, Bare/OVA, or PBS was injected into the side where the tumor had grown. (a) Suppression of tumor growth. (b) Surviving mice, expressed as a percentage of the total number of mice in each group.
